MedPath

Evaluation of the effect of zinc supplementation (Zn) in patients receiving methadone maintenance treatment

Phase 3
Recruiting
Conditions
addiction.
???? ????? ?????? ??????
F17.210
Registration Number
IRCT20200708048050N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients treated with methadone maintenance in the age range of 30 to 60 years

Exclusion Criteria

Positive urinary test for morphine, methamphetamine and cannabis
Do not have a specific disease
Zinc consumption in the last 3 months
High blood pressure
Consumption of psychiatric and neurological drugs during the study
Digestive problems and side effects of zinc consumption
Consumption of iron supplements

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Beck Depression Inventory.;Depression. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Beck Depression Inventory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath